Financial Consulate, Inc
- SEC CIK
- 0001624510
- Latest filing
- Jul 23, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Financial Consulate, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q2 2026)
- 800
- Value
- $195.8K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 800 | $195.8K | <0.1% | −417−34.3% | Reduced | Holders |
| Q1 2026 | 1,217 | $205.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,217 | $222.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,217 | $147.8K | <0.1% | +1,217 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −5,220−100.0% | Sold out | Holders |
| Q1 2023 | 5,220 | $322.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 5,220 | $402.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,220 | $233.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5,220 | $200.0K | 0.1% | +355+7.3% | Added | Holders |
| Q1 2022 | 4,865 | $201.0K | 0.1% | +4,865 | New | Holders |